User profiles for Byron Creese
 | Byron CreeseBrunel University London Verified email at brunel.ac.uk Cited by 3155 |
[HTML][HTML] Examining the association between genetic liability for schizophrenia and psychotic symptoms in Alzheimer's disease
Psychosis (delusions or hallucinations) in Alzheimer’s disease (AD + P) occurs in up to 50%
of individuals and is associated with significantly worse clinical outcomes. Atypical …
of individuals and is associated with significantly worse clinical outcomes. Atypical …
Cognitive decline in Parkinson disease
Dementia is a frequent problem encountered in advanced stages of Parkinson disease (PD).
In recent years, research has focused on the pre-dementia stages of cognitive impairment …
In recent years, research has focused on the pre-dementia stages of cognitive impairment …
The psychosis spectrum in Parkinson disease
In 2007, the clinical and research profile of illusions, hallucinations, delusions and related
symptoms in Parkinson disease (PD) was raised with the publication of a consensus definition …
symptoms in Parkinson disease (PD) was raised with the publication of a consensus definition …
Loneliness, physical activity, and mental health during COVID-19: a longitudinal analysis of depression and anxiety in adults over the age of 50 between 2015 and …
Objective:Loneliness and physical activity are important targets for research into the impact
of COVID-19 because they have established links with mental health, could be exacerbated …
of COVID-19 because they have established links with mental health, could be exacerbated …
[HTML][HTML] Psychosis in Alzheimer disease—mechanisms, genetics and therapeutic opportunities
Psychosis is a common and distressing symptom in people with Alzheimer disease, and few
safe and effective treatments are available. However, new approaches to symptom …
safe and effective treatments are available. However, new approaches to symptom …
Mild behavioral impairment as a marker of cognitive decline in cognitively normal older adults
Objective Mild behavioral impairment (MBI) is a neurobehavioral syndrome characterized
by later life emergent neuropsychiatric symptoms (NPS) that represent an at-risk state for …
by later life emergent neuropsychiatric symptoms (NPS) that represent an at-risk state for …
Atypical antipsychotics for the treatment of behavioral and psychological symptoms in dementia, with a particular focus on longer term outcomes and mortality
Importance of the field: Many people with Alzheimer's disease (AD) and other dementias
are prescribed atypical antipsychotics for behavioral and psychiatric symptoms such as …
are prescribed atypical antipsychotics for behavioral and psychiatric symptoms such as …
Vitamin D supplementation and incident dementia: Effects of sex, APOE, and baseline cognitive status
Introduction Despite the association of vitamin D deficiency with incident dementia, the role
of supplementation is unclear. We prospectively explored associations between vitamin D …
of supplementation is unclear. We prospectively explored associations between vitamin D …
Profile of mild behavioral impairment and factor structure of the Mild Behavioral Impairment Checklist in cognitively normal older adults
Objectives:In this large population study, we set out to examine the profile of mild behavioral
impairment (MBI) by using the Mild Behavioral Impairment Checklist (MBI-C) and to explore …
impairment (MBI) by using the Mild Behavioral Impairment Checklist (MBI-C) and to explore …
Treatment of behavioral and psychological symptoms of Alzheimer's disease
Opinion statement Behavioral and psychological symptoms of dementia (BPSD) are frequent
amongst people with Alzheimer’s disease (AD) and other dementias, commonly confer risk …
amongst people with Alzheimer’s disease (AD) and other dementias, commonly confer risk …